Anji Microelectronics Technology Shanghai Co Ltd
SSE:688019
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Anji Microelectronics Technology Shanghai Co Ltd
SSE:688019
|
CN |
|
NTT Data Intramart Corp
TSE:3850
|
JP |
|
PT Sentul City Tbk
IDX:BKSL
|
ID |
|
Brii Biosciences Ltd
HKEX:2137
|
CN |
|
Clinigen Group PLC
LSE:CLIN
|
UK |
|
China Zenith Chemical Group Ltd
HKEX:362
|
HK |
|
Nifco Inc
TSE:7988
|
JP |
|
T
|
Terna Energy SA
ATHEX:TENERGY
|
GR |
|
Takeda Printing Co Ltd
TSE:7875
|
JP |
Balance Sheet
Balance Sheet Decomposition
Anji Microelectronics Technology Shanghai Co Ltd
Anji Microelectronics Technology Shanghai Co Ltd
Balance Sheet
Anji Microelectronics Technology Shanghai Co Ltd
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
170
|
65
|
140
|
455
|
336
|
330
|
329
|
528
|
894
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
330
|
329
|
528
|
894
|
|
| Cash Equivalents |
170
|
65
|
140
|
455
|
336
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
51
|
500
|
220
|
169
|
61
|
45
|
|
| Total Receivables |
42
|
49
|
61
|
56
|
74
|
202
|
253
|
293
|
404
|
|
| Accounts Receivables |
39
|
44
|
54
|
52
|
66
|
177
|
236
|
282
|
393
|
|
| Other Receivables |
3
|
6
|
7
|
4
|
9
|
25
|
17
|
11
|
12
|
|
| Inventory |
49
|
63
|
70
|
77
|
105
|
230
|
366
|
427
|
618
|
|
| Other Current Assets |
3
|
88
|
80
|
235
|
7
|
13
|
29
|
33
|
66
|
|
| Total Current Assets |
264
|
266
|
350
|
874
|
1 022
|
996
|
1 146
|
1 342
|
2 026
|
|
| PP&E Net |
35
|
56
|
61
|
92
|
205
|
507
|
593
|
675
|
793
|
|
| PP&E Gross |
35
|
56
|
61
|
92
|
205
|
507
|
593
|
675
|
793
|
|
| Accumulated Depreciation |
42
|
46
|
53
|
55
|
64
|
99
|
165
|
226
|
319
|
|
| Intangible Assets |
2
|
7
|
7
|
7
|
11
|
12
|
34
|
80
|
79
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
11
|
101
|
209
|
314
|
339
|
|
| Other Long-Term Assets |
12
|
24
|
16
|
19
|
39
|
57
|
66
|
184
|
213
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
0
|
|
| Total Assets |
313
N/A
|
354
+13%
|
433
+23%
|
991
+129%
|
1 287
+30%
|
1 672
+30%
|
2 048
+22%
|
2 603
+27%
|
3 452
+33%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
18
|
15
|
28
|
21
|
61
|
81
|
86
|
81
|
143
|
|
| Accrued Liabilities |
9
|
4
|
5
|
10
|
11
|
15
|
27
|
30
|
61
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
22
|
16
|
30
|
10
|
130
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
27
|
24
|
32
|
69
|
|
| Other Current Liabilities |
19
|
28
|
37
|
49
|
115
|
194
|
210
|
41
|
63
|
|
| Total Current Liabilities |
46
|
48
|
69
|
79
|
209
|
332
|
377
|
193
|
467
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
117
|
129
|
177
|
197
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
9
|
0
|
2
|
7
|
4
|
|
| Other Liabilities |
5
|
4
|
17
|
25
|
22
|
22
|
19
|
102
|
84
|
|
| Total Liabilities |
51
N/A
|
52
+2%
|
87
+67%
|
104
+20%
|
239
+131%
|
471
+97%
|
526
+12%
|
479
-9%
|
751
+57%
|
|
| Equity | ||||||||||
| Common Stock |
40
|
40
|
40
|
53
|
53
|
53
|
75
|
99
|
129
|
|
| Retained Earnings |
74
|
14
|
59
|
125
|
259
|
368
|
653
|
1 023
|
1 523
|
|
| Additional Paid In Capital |
296
|
247
|
247
|
709
|
736
|
780
|
792
|
1 019
|
1 068
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
20
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
262
N/A
|
302
+15%
|
347
+15%
|
888
+156%
|
1 048
+18%
|
1 201
+15%
|
1 522
+27%
|
2 124
+40%
|
2 701
+27%
|
|
| Total Liabilities & Equity |
313
N/A
|
354
+13%
|
433
+23%
|
991
+129%
|
1 287
+30%
|
1 672
+30%
|
2 048
+22%
|
2 603
+27%
|
3 452
+33%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
123
|
123
|
123
|
163
|
163
|
164
|
164
|
167
|
168
|
|